昊海生科：关于开立募集资金现金管理产品专用结算账户的公告

Group 1 - The company, Haohai Biological Technology, announced the convening of its sixth board meeting on November 7, 2025, to review a proposal for cash management using temporarily idle raised funds [2] - The board approved the use of up to RMB 300 million (including principal) of temporarily idle raised funds for cash management, ensuring that it does not affect the normal investment plans of the raised funds [2] - The cash management will involve purchasing investment products that are safe, liquid, and have capital protection agreements, including but not limited to agreement deposits, notice deposits, time deposits, large certificates of deposit, and income certificates [2]